ChronoScale Corporation Common Stock (NASDAQ:CHRN) Shares Down 16.1% – Here’s What Happened

ChronoScale Corporation Common Stock (NASDAQ:CHRN) shares dropped 16.1% on Wednesday. The company traded as low as $11.41 and last traded at $11.48. 145,743 shares were traded during trading, a decline of 34% from the average session volume of 221,623 shares. The stock had previously closed at $13.68.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on CHRN. Northland Securities initiated coverage on shares of ChronoScale Corporation Common Stock in a research note on Friday, September 18th. They issued an “outperform” rating and a $32.00 price target for the company. Compass Point began coverage on shares of ChronoScale Corporation Common Stock in a research note on Friday, October 16th. They set a “buy” rating and a $25.00 price objective on the stock. Finally, Weiss Ratings cut shares of ChronoScale Corporation Common Stock from a “sell (d)” rating to a “sell (d-)” rating in a report on Friday, October 23rd. Two equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $21.00.

ChronoScale Corporation Common Stock Stock Down 14.3%

The stock has a market cap of $1.71 billion, a P/E ratio of -2.72 and a beta of 1.12. The firm has a 50 day simple moving average of $18.22 and a 200-day simple moving average of $16.02. The company has a quick ratio of 0.30, a current ratio of 0.30 and a debt-to-equity ratio of 0.02.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last issued its earnings results on Wednesday, October 14th. The company reported ($0.29) EPS for the quarter. The business had revenue of $41.48 million for the quarter. ChronoScale Corporation Common Stock had a negative return on equity of 66.16% and a negative net margin of 135.66%. On average, equities research analysts forecast that ChronoScale Corporation Common Stock will post -0.49 earnings per share for the current fiscal year.

ChronoScale Corporation Common Stock Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.